In 1965, Stéarinerie Dubois left Montreuil in the Paris region to settle in Indre.
Relocation alone has not solved the structural problems of the business.
Radical decisions are made. The company stops manufacturing stearin and abandons the Maubec industry. This process using acetone was quickly abandoned after its installation, following an accident that negated this investment. It is refocusing on the repackaging of stearin and glycerin purchased from international industrial manufacturers. This new strategy is accompanied by a significant reduction in staff.
Dr Alain Gondrand, once again injects capital into the company. Over the course of the capital increases, he became the largest shareholder of the Dubois stéarinerie.
The following years, the company will survive painfully by trading and packaging stearin, various fatty acids and glycerin. It then sources its supplies from a large group, the Unilever company. Times have changed: small artisanal fatty acid producers no longer have their place in the face of large international oleochemical companies.
Doctor Alain Gondrand died suddenly in June 1980. His son Henri Gondrand, then aged 29, agreed to manage his estate. Unable to abandon this industrial site, then occupying 27 people, he made the decision, without being particularly prepared, to take up the challenge of taking over and re-establishing the company, of which he became CEO on May 10, 1982.
In March 1981, Henri Gondrand met Paul Dietram Droste, a chemical engineer specializing in fatty substances, then looking for a job. They decide to team up.
Seeing the potential for development of the cosmetics industry, management is reorienting the activity of Stéarinerie Dubois towards the synthesis of fatty acid esters. After securing the site beforehand, the company is installing second-hand equipment and building esterification reactors, in order to be able to industrially produce these new products, “the Esters”. It sources its supplies from a new supplier, Mira Lanza, and renegotiates its debt with Unilever.
Building on its initial successes, the company invests, modernizes itself and, through tenacity and hard work, wins markets with the major cosmetic and pharmaceutical players of the time.